Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Immunological monitoring for prediction of clinical response to antitumor vaccine therapy.
Mikhaylova IN, Shubina IZ, Chkadua GZ, Petenko NN, Morozova LF, Burova OS, Beabelashvili RS, Parsunkova KA, Balatskaya NV, Chebanov DK, Pospelov VI, Nazarova VV, Vihrova AS, Cheremushkin EA, Molodyk AA, Kiselevsky MV, Demidov LV. Mikhaylova IN, et al. Among authors: shubina iz. Oncotarget. 2018 May 11;9(36):24381-24390. doi: 10.18632/oncotarget.25274. eCollection 2018 May 11. Oncotarget. 2018. PMID: 29849947 Free PMC article.
Immune Pathogenesis of COVID-19 Intoxication: Storm or Silence?
Kiselevskiy M, Shubina I, Chikileva I, Sitdikova S, Samoylenko I, Anisimova N, Kirgizov K, Suleimanova A, Gorbunova T, Varfolomeeva S. Kiselevskiy M, et al. Among authors: shubina i. Pharmaceuticals (Basel). 2020 Jul 26;13(8):166. doi: 10.3390/ph13080166. Pharmaceuticals (Basel). 2020. PMID: 32722596 Free PMC article. Review.
Real-World Experience with Targeted Therapy in BRAF Mutant Advanced Melanoma Patients: Results from a Multicenter Retrospective Observational Study Advanced Melanoma in Russia (Experience) (ADMIRE).
Orlova KV, Ledin EV, Zhukova NV, Orlova RV, Karabina EV, Volkonskiy MV, Stroyakovskiy DL, Yurchenkov AN, Protsenko SA, Novik AV, Vorotilina LV, Moiseenko FV, Chang VL, Kazmin AI, Tkachenko SA, Gamaunov SV, Naskhletashvili DR, Samoylenko IV, Vikhrova AS, Utyashev IA, Kharkevich GY, Petenko NN, Shubina IZ, Demidov LV. Orlova KV, et al. Among authors: shubina iz. Cancers (Basel). 2021 May 21;13(11):2529. doi: 10.3390/cancers13112529. Cancers (Basel). 2021. PMID: 34064013 Free PMC article.
[Adoptive immunotherapy of malignancies].
Shubina IZh, Bliumenberg AG, Volkov SM, Demidov LV, Kiselevskiĭ MV. Shubina IZh, et al. Vestn Ross Akad Med Nauk. 2007;(11):9-15. Vestn Ross Akad Med Nauk. 2007. PMID: 18080522 Review. Russian.
Novel and Promising Strategies for Therapy of Post-Transplant Chronic GVHD.
Kostareva I, Kirgizov K, Machneva E, Ustyuzhanina N, Nifantiev N, Skvortsova Y, Shubina I, Reshetnikova V, Valiev T, Varfolomeeva S, Kiselevskiy M. Kostareva I, et al. Among authors: shubina i. Pharmaceuticals (Basel). 2022 Sep 3;15(9):1100. doi: 10.3390/ph15091100. Pharmaceuticals (Basel). 2022. PMID: 36145321 Free PMC article. Review.
Update on the challenges and recent advances in cancer immunotherapy.
Baronzio G, Parmar G, Shubina IZh, Cassutti V, Giuli S, Ballerini M, Kiselevsky M. Baronzio G, et al. Immunotargets Ther. 2013 Jun 15;2:39-49. doi: 10.2147/ITT.S30818. eCollection 2013. Immunotargets Ther. 2013. PMID: 27471687 Free PMC article. Review.
39 results